Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Frontiers in Immunology|August 1, 2020
Viral Evasion of the Complement System and Its Importance for Vaccines and TherapeuticsJack Mellors, Tom Tipton, Stephanie Longet, et al.Frontiers in Immunology|April 17, 2023
Pre-clinical models to define correlates of protection for SARS-CoV-2Caolann Brady, Tom Tipton, Stephanie Longet, et al.Frontiers in Immunology|March 8, 2021
Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of ProtectionStephanie Longet, Jack Mellors, Miles W Carroll, et al.Pathogens (Basel, Switzerland)|September 28, 2021
Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic ApplicationAlexander Hargreaves, Caolann Brady, Jack Mellors, et al.Frontiers in Immunology|April 21, 2022
Vaccine-Associated Enhanced Disease and Pathogenic Human CoronavirusesCillian Gartlan, Tom Tipton, Francisco J Salguero, et al.NPJ Vaccines|April 14, 2025
A systems biology approach to define SARS-CoV-2 correlates of protectionCaolann Brady, Tom Tipton, Oliver Carnell, et al.Nature Communications|March 19, 2025
Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individualsJack Mellors, Raman Dhaliwal, Stephanie Longet, et al.Journal of Virological Methods|October 26, 2024
Performance of an envelope glycoprotein-based multiplex immunoassay for Ebola virus antibody detection in a cohort of Ebola virus disease survivorsMcKenna D Roe, Grace Hood, Spencer L Sterling, et al.Microbiology Spectrum|March 22, 2023
Linked Mutations in the Ebola Virus Polymerase Are Associated with Organ Specific PhenotypesXiaofeng Dong, Julia Tree, Logan Banadyga, et al.Frontiers in Immunology|September 26, 2022
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individualsStephanie Longet, Alexander Hargreaves, Saoirse Healy, et al.Pageof 4